Hirsutism of adrenal origin in adolescents: Consequences in adults

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue SUPPL. 5, 2001, Pages 1309-1315

  Kelestimur F ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Adrenal hyperandrogenism; Adrenocortical tumors; Anti androgens; Hirsutism; Non classical congenital adrenal hyperplasia; Polycystic ovary syndrome; Treatment

Indexed keywords

CORTICOTROPIN; CYPROTERONE ACETATE; DEXAMETHASONE; DIANE; ESTRADIOL; FINASTERIDE; FLUTAMIDE; GLUCOCORTICOID; HYDROCORTISONE; PREDNISONE; SPIRONOLACTONE;

ADOLESCENT; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL DISEASE; ADULT; ARTICLE; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; HIRSUTISM; HUMAN; IDIOPATHIC DISEASE; MALE; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; SIDE EFFECT; SYMPTOM;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND DISEASES; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROGEN ANTAGONISTS; FEMALE; HIRSUTISM; HUMANS;

EID: 0035179003     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hirsutism
2. Dehydroepiandrosterone sulfate as an indicator of adrenal androgen function
3. Steroid hormone-producing tumors in man
4. Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery
5. Adrenocortical carcinoma
6. Androgen-secreting-adrenal neoplasms
7. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome
8. Skin manifestations of Cushing disease in children and adolescents before and after the resolution of hypercortisolemia
9. Identifying an adrenal disorder in the hirsute women
10. Hirsutism
11. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: A marker of adrenocortical tumor
12. Outcome in patients with adrenal incidentaloma selected for surgery: An analysis of 88 cases investigated in a single clinical center
13. Congenital adrenal hyperplasia
14. High frequency of nonclassical steroid 21-hydroxylase deficiency
15. Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy
16. Clinical review 56: Non-classic adrenal hyperplasia: Current concepts
17. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
18. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms
19. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency
20. Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico
21. Overdiagnosis of 21-hydroxylase late onset congenital adrenal hyperplasia: Correlation of corticotropin test and human leukocyte antigen typing
22. Late-onset adrenal hyperplasia in hirsutism
23. Prevalence of late-onset 11β-hydroxylase deficiency in hirsute patients
24. 11β-Hydroxylase deficiency in hyperandrogenism
25. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia
26. The prevalence of non-classic adrenal hyperplasia due to 11β-hydroxylase deficiency among hirsute women in a Turkish population
27. Congenital adrenal hyperplasia with 11-hydroxylase deficiency. A case report and contribution to diagnosis
28. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. A study of 25 patients
29. Evidence for adrenal and for ovarian dysfunction as a possible etiology of idiopathic hirsutism
30. The incidence of late-onset congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency among hirsute women
31. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism
32. Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: Adrenal enzyme defects and exaggerated adrenarche
33. The clinical spectrum of congenital adrenal hyperplasia in adolescence and adulthood
34. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency
35. Disorders of the aldosterone synthase and steroid 11β-hydroxylase deficiency
36. An alternate pathway to androstenedione synthesis by human adrenals: Evidence of a balance in 11β-hydroxylase and 17,20-lyase activities leading to androstenedione
37. Alternate pathway 17,20-lyase enzyme activity in the adrenals is enhanced in patients with polycystic ovary syndrome
38. Influence of metyrapone on plasma concentrations of testosterone and androstenedione in man
39. Plasma 11-deoxycortisol, androstenedione, testosterone, and ACTH in comparison of tetra-11-deoxycortisol as indices of the pituitary adrenal response to oral metyrapone
40. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital hyperplasia due to 21-hydroxylase deficiency
41. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women
42. Bioavailability of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
43. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency
44. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia
45. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism
46. The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors
47. Finasteride treatment for one year in 35 hirsute patients
48. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
49. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues
50. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism
51. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism